ZEB1 and Familial prostate cancer: Later, ZEB1-AS1 was found to act as an oncogene in multiple tumors, including prostate cancer, colorectal cancer, bladder cancer, osteosarcoma, glioma, esophageal squamous cell carcinoma, and B lymphocytic leukemia [14].